diabetes

Showing NaN - NaN of 113

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Enrolling by invitation
  • Diabetes
  • +4 more
    • Phoenix, Arizona
    • +26 more
    Jan 19, 2023

    Osteomyelitis, Diabetes, Amputation Trial in United States (Rifampin, Riboflavin Placebo)

    Recruiting
    • Osteomyelitis
    • +2 more
    • Phoenix, Arizona
    • +29 more
    Jan 13, 2023

    Diabetes, Myocardial Infarction, Stroke Trial in United States (Lifestyle Intervention, Diabetes Support and Education)

    Completed
    • Diabetes
    • +5 more
    • Lifestyle Intervention
    • Diabetes Support and Education
    • Birmingham, Alabama
    • +17 more
    Sep 27, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +105 more
    Jul 11, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Lancaster, California
    • +104 more
    Jul 11, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +107 more
    Jul 11, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +241 more
    Jul 11, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Little Rock, Arkansas
    • +228 more
    Jul 11, 2022

    Diabetes Trial in San Antonio (metformin\pioglitazone\exenatide, metformin, glyburide and glargine)

    Active, not recruiting
    • Diabetes
    • San Antonio, Texas
      Texas Diabetes Institute
    Mar 8, 2022

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Insulin degludec
    • Insulin glargine
    • Anniston, Alabama
    • +228 more
    Jan 6, 2022

    Diabetes, Hyperlipidemia, Hypertension Trial in United States (CVRS Intervention)

    Completed
    • Diabetes
    • +3 more
    • CVRS Intervention
    • Gainesville, Florida
    • +17 more
    Jul 22, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +184 more
    Jul 1, 2021

    NASH, NASH - Nonalcoholic Steatohepatitis, Type 2 Diabetes Trial in Fort Myers, San Antonio (MET409 Active, MET409 Placebo,

    Active, not recruiting
    • NASH
    • +7 more
    • MET409 Active
    • +2 more
    • Fort Myers, Florida
    • +1 more
    May 28, 2021

    Diabetes Trial in United States (, Oral Hepatic Directed Vesicles (HDV)-Insulin (U-15), Oral Hepatic Directed Vesicles

    Completed
    • Diabetes
    • placebo
    • +2 more
    • Muscle Shoals, Alabama
    • +39 more
    May 24, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tucson, Arizona
    • +102 more
    Jan 14, 2021

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Glendale, Arizona
    • +87 more
    Aug 10, 2020

    Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)

    Unknown status
    • Overweight
    • +3 more
    • Gelesis200
    • Placebo
    • Birmingham, Alabama
    • +29 more
    Jul 20, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +231 more
    Jun 16, 2020

    Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

    Completed
    • Diabetes
    • Birmingham, Alabama
    • +83 more
    Jun 22, 2020

    Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

    Completed
    • Stroke
    • +2 more
    • Birmingham, Alabama
    • +182 more
    Apr 14, 2020

    Diabetes Trial in United States (GuardianĀ® blood-sugar monitoring device)

    Terminated
    • Diabetes
    • GuardianĀ® blood-sugar monitoring device
    • Dallas, Texas
    • +5 more
    Mar 6, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +116 more
    Feb 14, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anaheim, California
    • +118 more
    Jan 8, 2020

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec/liraglutide
    • insulin glargine
    • Muscle Shoals, Alabama
    • +142 more
    Nov 8, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Insulin degludec/insulin aspart
    • +2 more
    • Glendale, Arizona
    • +70 more
    Nov 8, 2019